CymaBay Therapeutics Logo Image

CymaBay Therapeutics

Most Recent Annual Report

2017 Annual Report and Form 10K

CymaBay Therapeutics

CymaBay Therapeutics has reached its limit for free report views.

CymaBay Therapeutics does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About CymaBay Therapeutics

11-50 Employees
Based in Newark, California

CymaBay Therapeutics, Inc. (CBAY) is a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, including serious rare and orphan disorders. MBX-8025 is a potent, selective, orally active PPARδ agonist.

Ticker:
CBAY
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol